After her training in Internal Medicine and Infectious Diseases and board examinations at the University of Basel, Nina Khanna did postdoctoral fellowships in transplant virology at Prof Hans Hirsch Lab at the Department of Biomedicine in Basel and in the field of T-cell immunology and T-cell therapy at the University Hospital of Würzburg in Prof. Einsele/Prof. Topps’ group.
Since 2013, she is an independent research group leader at the Department of Biomedicine at the University and University Hospital of Basel and was supported from 2013 to 2016 through an Ambizione Score grant by the SNSF. During that time, she set up a GMP and Swissmedic-certified protocol for virus specific T-cell therapy for treatment refractory viral infections in patients after hematopoietic stem cell and solid organ transplantation.
In 2017 she was promoted to a senior physician responsible for transplant infectious diseases at the University Hospital of Basel. The research focuses on infection biology in bacterial and fungal infections. She explores underlying mechanism of host-pathogen interaction in infectious diseases in a strong translational setting and investigates new treatment strategies in pre-clinical mouse models and in humans with the overarching goal to improve outcome of infections.
She is a member of the management team and the responsible person for the clinical studies of the National Center of Competence in Research (NCCR) “AntiResist”, which aims at identifying new approaches to combat antibiotic-resistant bacteria. She is a member of the infectious diseases working group of the Swiss Transplant Cohort and the current president of FUNGINOS.